Latest filing published 04 Nov 2026 for Nurix Therapeutics, Inc., €109k.
Insider track record
No signal scores available.
Johannes van Houte: trading record in brief
Johannes van Houte discloses dealings in Nurix Therapeutics, Inc. to SEC (Form 4). Between 4 August 2026 and 4 November 2026, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 4 November 2026, the filings show a transaction worth €109k in Nurix Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Johannes van Houte
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,769 shares@ US$25.82CommonSEC144:0001950047-26-010683
- 4,761 shares@ US$23.220.0046% mcap100.0% of flowCommonSEC144:0001950047-26-007637
2 of 2 declarations
